Evans Melanie
Mod Healthc. 2013 May 13;43(19):6-7, 1.
Leaders of pharmaceutical companies were among the highest-paid healthcare industry executives in 2012. In that sector, executive compensation packages can be weighted with equity that bring large payouts when the company does well. Dr. George Yancopoulos of Regeneron, left, eamed a salary of $850,000 and a $2 million bonus last year, but came away with benefits totaling $81.6 million with the addition of stock and option awards.
制药公司的高管是2012年医疗行业薪酬最高的管理人员之一。在该行业，高管薪酬方案可能会偏重股权，当公司业绩良好时会带来巨额收益。再生元公司的乔治·扬科波洛斯博士（左）去年年薪85万美元，奖金200万美元，但加上股票和期权奖励，其总福利达8160万美元。
